- TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis
- TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member
- TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology
- TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient
- TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition
Category Archives: Business / Finance
TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis
The biotech company TcLand Expression is pleased to announce the financial support awarded by Oseo and the European Regional Development Fund (ERDF) for the validation study of the first companion diagnostic test in rheumatoid arthritis. The program is mainly dedicated … Continue reading
TcLand Expression signs a licensing agreement with Inserm Transfert and initiates a strategic collaboration on the development of companion diagnostic tests for rheumatoid arthritis therapies. EN. FR.
TcLand Expression and its collaborative partners receive €450,000 in funding from the French National Research Agency for the company’s companion diagnostic program in rheumatoid arthritis. EN. FR.